It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids and over-the-counter medications.
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.
Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now.
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC News reported.
The Justice Department filed a lawsuit against Walgreens accusing the drugstore giant of filling millions of illegitimate prescriptions across the country since 2012.
The Washington state Department of Health launched ... Washingtonians live healthy and fulfilling lives, and to stop this opioid crisis from robbing those lives from our neighbors, friends ...
The intensifying focus in Washington has triggered a new level of interest on ... Food companies have tapped into “the same neural circuits that are involved in opioid addiction,” Califf said at the hearing. Sanders, who presided over the hearing ...
Patrick Kennedy suggests Robert F. Kennedy Jr. would be open to use of addiction medications as well as "wellness farms" for opioid use disorder.
The settlement, in principle, would not shield Purdue Pharma or the Sackler family from additional liability over their role in the opioid crisis.
The Justice Department has filed a civil lawsuit against Walgreens, accusing the 124-year-old pharmacy chain of dispensing millions of unlawful prescriptions over a period of several years.
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.